Initial treatment of well-differentiated neuroendocrine tumors.
Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Arvind
A
Dasari
James
J
Yao
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002454:Cell Differentiation; D003131:Combined Modality Therapy; D006801:Humans; D018358:Neuroendocrine Tumors / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*; D011379:Prognosis
D000970:Antineoplastic Agents